Hjem › Hypertrofisk kardiomyopati › Minnesota
Hypertrofisk kardiomyopati kliniske forsøg i Minnesota
3 studier for Hypertrofisk kardiomyopati søger deltagere på steder i Minnesota.
Officiel studietekst (engelsk)
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
- Minneapolis Heart Institute Foundation, Minneapolis
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 19. aug. 2026 · NCT05489705A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
- Imbria Investigational Site, Rochester
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 18. maj 2026 · NCT07023614Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM
- Mayo Clinic, Rochester
RekruttererFase 1/2
Alder 18 til 75 · Alle køn · Opdateret 19. mar. 2026 · NCT05836259Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.